SHOULD SURGICAL PATIENTS BE SCREENED FOR HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION

被引:8
作者
SHANSON, DC
机构
[1] Department of Medical Microbiology, Charing Cross and Westminster Medical School, London, SW1P 2AR
关键词
HUMAN IMMUNODEFICIENCY VIRUS; SURGERY; SCREENING METHODS;
D O I
10.1016/0195-6701(91)90020-9
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
There are increasingly strong arguments for the introduction of wider screening of all kinds of patients, including surgical patients, to diagnose otherwise undetected human immunodeficiency virus (HIV) infection in order to facilitate earlier treatment of HIV infection with zidovudine. Wider screening may also help to limit the spread of HIV in the community as infected patients may be counselled and more effective public health measures planned. In areas of high prevalence voluntary universal screening test programmes should be encouraged whereas in areas of low to medium prevalence more selective screening tests would be appropriate on people belonging to risk groups. Screening of patients undergoing elective surgery for infection control purposes is most appropriate in areas of low to medium prevalence so that extra precautions in the operating theatre can be selected for those patients who are screened and deemed to be at high risk. Screening methods include taking a comprehensive clinical history to include specific questions about risk group behaviour, questionnaire methods, serological screening tests and a combination of these three types of approach. Screening HIV antibody tests are recommended, with informed consent, of those patients who belong to risk groups. A further benefit of screening for infection control purposes occurs in the event of a sharps injury when prior testing of the source patient helps to facilitate decision making about the giving of immediate zidovudine prophylaxis. © 1991.
引用
收藏
页码:170 / 176
页数:7
相关论文
共 9 条
[1]  
BACHNER P, 1990, ARCH PATHOL LAB MED, V114, P319
[2]   MEASUREMENT OF THE FALSE POSITIVE RATE IN A SCREENING-PROGRAM FOR HUMAN IMMUNODEFICIENCY VIRUS-INFECTIONS [J].
BURKE, DS ;
BRUNDAGE, JF ;
REDFIELD, RR ;
DAMATO, JJ ;
SCHABLE, CA ;
PUTMAN, P ;
VISINTINE, R ;
KIM, HI .
NEW ENGLAND JOURNAL OF MEDICINE, 1988, 319 (15) :961-964
[3]  
DUDLEY H, 1989, AUG INT C BLOOD BORN, P62
[4]   THE SAFETY AND EFFICACY OF ZIDOVUDINE (AZT) IN THE TREATMENT OF SUBJECTS WITH MILDLY SYMPTOMATIC HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV) INFECTION - A DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL [J].
FISCHL, MA ;
RICHMAN, DD ;
HANSEN, N ;
COLLIER, AC ;
CAREY, JT ;
PARA, MF ;
HARDY, WD ;
DOLIN, R ;
POWDERLY, WG ;
ALLAN, JD ;
WONG, B ;
MERIGAN, TC ;
MCAULIFFE, VJ ;
HYSLOP, NE ;
RHAME, FS ;
BALFOUR, HH ;
SPECTOR, SA ;
VOLBERDING, P ;
PETTINELLI, C ;
ANDERSON, J .
ANNALS OF INTERNAL MEDICINE, 1990, 112 (10) :727-737
[5]   NEEDLESTICK INJURIES, SURGEONS, AND HIV RISKS [J].
LEENTVAARKUIJPERS, A ;
DEKKER, MM ;
COUTINHO, RA ;
DEKKER, EE ;
KEEMAN, JN ;
ANSINKSCHIPPER, MC .
LANCET, 1990, 335 (8688) :546-547
[6]  
MCKINNEY WP, 1990, INFECT CONT HOSP EP, V11, P243
[8]   THE CASE FOR WIDER USE OF TESTING FOR HIV INFECTION [J].
RHAME, FS ;
MAKI, DG .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 320 (19) :1248-1254
[9]  
SIM AJW, 1990, AIDS SURGERY, P30